CoChat

Impact of Antibiotics on Necrotizing Enterocolitis and Antibiotic-Associated Diarrhea

Open access
Silverman, Michael A., Konnikova, Liza, Gerber, Jeffrey S. · 2017 · Gastroenterology Clinics of North America
Cited by 110

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.

Abstract

Summary Antibiotics induce changes or dysbiosis of the intestinal microbiome. These antibiotic-induce changes may contribute to the pathogenesis of necrotizing enterocolitis (NEC) and antibiotic-associated diarrhea (AAD). Studies are beginning to unravel the contribution of specific groups of microbes to these diseases—most notably Gammaproteobacteria for NEC and bile acid- and carbohydrate-metabolizing microbes for AAD. Antibiotic-associated diarrhea occurs when antibiotic treatment induces diarrhea by altering the metabolic function of the patient’s intestinal microbiota leading to either an osmotic or infectious diarrhea, most notably Clostridium difficile infection (CDI). Antibiotic therapy impairs the host microbiota’s ability to resist colonization or expansion of pathogenic bacteria. In the case of CDI, there is growing evidence that microbiota-mediated bile acid metabolism is critical in the pathogenesis of this infection. Probiotics or other microbiota-targeted therapies may provide effective strategies to prevent and treat NEC and AAD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.gtc.2016.09.010

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 76

  1. Chai, 2012, Trends of outpatient prescription drug utilization in US children, 2002-2010, Pediatrics, 130, 23, 10.1542/peds.2011-2879 · DOI · Paper page
  2. Hicks, 2015, US outpatient antibiotic prescribing variation according to geography, patient population, and provider specialty in 2011, Clin Infect Dis, 60, 1308, 10.1093/cid/civ076 · DOI · Paper page
  3. Robinson, 2010, Antibiotic administration alters the community structure of the gastrointestinal microbiota, Gut Microbes, 1, 279, 10.4161/gmic.1.4.12614 · DOI · Paper page
  4. Giuliano, 1987, Effect of broad-spectrum parenteral antibiotics on composition of intestinal microflora of humans, Antimicrob Agents Chemother, 31, 202, 10.1128/AAC.31.2.202 · DOI · Paper page
  5. Stappenbeck, 2002, Developmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells, Proc Natl Acad Sci U S A, 99, 15451, 10.1073/pnas.202604299 · DOI · Paper page
  6. Joly, 2009, Morphological adaptation with preserved proliferation/transporter content in the colon of patients with short bowel syndrome, Am J Physiol Gastrointest Liver Physiol, 297, G116, 10.1152/ajpgi.90657.2008 · DOI
  7. Turnbaugh, 2007, The human microbiome project, Nature, 449, 804, 10.1038/nature06244 · DOI · Paper page
  8. Groer, 2014, Development of the preterm infant gut microbiome: a research priority, Microbiome, 2, 38, 10.1186/2049-2618-2-38 · DOI · Paper page
  9. Fujimura, 2010, Role of the gut microbiota in defining human health, Expert Rev Anti Infect Ther, 8, 435, 10.1586/eri.10.14 · DOI · Paper page
  10. Stout, 2013, Identification of intracellular bacteria in the basal plate of the human placenta in term and preterm gestations, Am J Obstet Gynecol, 208, 226.e1-7, 10.1016/j.ajog.2013.01.018 · DOI · Paper page
  11. Aagaard, 2014, The placenta harbors a unique microbiome, Sci Transl Med, 6, 237ra65, 10.1126/scitranslmed.3008599 · DOI · Paper page
  12. Satokari, 2009, Bifidobacterium and Lactobacillus DNA in the human placenta, Lett Appl Microbiol, 48, 8, 10.1111/j.1472-765X.2008.02475.x · DOI · Paper page
  13. Lauder, 2016, Comparison of placenta samples with contamination controls does not provide evidence for a distinct placenta microbiota, Microbiome, 4, 29, 10.1186/s40168-016-0172-3 · DOI · Paper page
  14. Costello, 2012, The application of ecological theory toward an understanding of the human microbiome, Science, 336, 1255, 10.1126/science.1224203 · DOI · Paper page
  15. Yatsunenko, 2012, Human gut microbiome viewed across age and geography, Nature, 486, 222, 10.1038/nature11053 · DOI · Paper page
  16. Mueller, 2015, Prenatal exposure to antibiotics, cesarean section and risk of childhood obesity, Int J Obes, 39, 665, 10.1038/ijo.2014.180 · DOI · Paper page
  17. Metsala, 2015, Prenatal and post-natal exposure to antibiotics and risk of asthma in childhood, Clin Exp Allergy, 45, 137, 10.1111/cea.12356 · DOI · Paper page
  18. Madan, 2016, Association of cesarean delivery and formula supplementation with the intestinal microbiome of 6-week-old infants, JAMA Pediatr, 170, 212, 10.1001/jamapediatrics.2015.3732 · DOI · Paper page
  19. Neu, 2011, Cesarean versus vaginal delivery: long-term infant outcomes and the hygiene hypothesis, Clin Perinatol, 38, 321, 10.1016/j.clp.2011.03.008 · DOI · Paper page
  20. Renz-Polster, 2005, Caesarean section delivery and the risk of allergic disorders in childhood, Clin Exp Allergy, 35, 1466, 10.1111/j.1365-2222.2005.02356.x · DOI · Paper page
  21. Decker, 2010, Cesarean delivery is associated with celiac disease but not inflammatory bowel disease in children, Pediatrics, 125, e1433, 10.1542/peds.2009-2260 · DOI · Paper page
  22. Fernandez, 2013, The human milk microbiota: origin and potential roles in health and disease, Pharmacol Res, 69, 1, 10.1016/j.phrs.2012.09.001 · DOI · Paper page
  23. Azad, 2013, Gut microbiota of healthy Canadian infants: profiles by mode of delivery and infant diet at 4 months, CMAJ, 185, 385, 10.1503/cmaj.121189 · DOI · Paper page
  24. Bezirtzoglou, 2011, Microbiota profile in feces of breast- and formula-fed newborns by using fluorescence in situ hybridization (FISH), Anaerobe, 17, 478, 10.1016/j.anaerobe.2011.03.009 · DOI · Paper page
  25. Fouhy, 2012, High-throughput sequencing reveals the incomplete, short-term recovery of infant gut microbiota following parenteral antibiotic treatment with ampicillin and gentamicin, Antimicrob Agents Chemother, 56, 5811, 10.1128/AAC.00789-12 · DOI · Paper page
  26. Mai, 2011, Fecal microbiota in premature infants prior to necrotizing enterocolitis, PLoS One, 6, e20647, 10.1371/journal.pone.0020647 · DOI · Paper page
  27. Morowitz, 2011, Strain-resolved community genomic analysis of gut microbial colonization in a premature infant, Proc Natl Acad Sci U S A, 108, 1128, 10.1073/pnas.1010992108 · DOI · Paper page
  28. Moles, 2013, Bacterial diversity in meconium of preterm neonates and evolution of their fecal microbiota during the first month of life, PLoS One, 8, e66986, 10.1371/journal.pone.0066986 · DOI · Paper page
  29. Claud, 2013, Bacterial community structure and functional contributions to emergence of health or necrotizing enterocolitis in preterm infants, Microbiome, 1, 20, 10.1186/2049-2618-1-20 · DOI · Paper page
  30. Walker, 2011, Necrotizing enterocolitis, N Engl J Med, 364, 255, 10.1056/NEJMra1005408 · DOI · Paper page
  31. Yee, 2012, Incidence and timing of presentation of necrotizing enterocolitis in preterm infants, Pediatrics, 129, e298, 10.1542/peds.2011-2022 · DOI · Paper page
  32. Afrazi, 2011, New insights into the pathogenesis and treatment of necrotizing enterocolitis: toll-like receptors and beyond, Pediatr Res, 69, 183, 10.1203/PDR.0b013e3182093280 · DOI
  33. Raveh-Sadka, 2015, Gut bacteria are rarely shared by co-hospitalized premature infants, regardless of necrotizing enterocolitis development, Elife, 4, 10.7554/eLife.05477 · DOI · Paper page
  34. Normann, 2013, Intestinal microbial profiles in extremely preterm infants with and without necrotizing enterocolitis, Acta Paediatr, 102, 129, 10.1111/apa.12059 · DOI · Paper page
  35. Torrazza, 2013, Intestinal microbial ecology and environmental factors affecting necrotizing enterocolitis, PLoS One, 8, e83304, 10.1371/journal.pone.0083304 · DOI · Paper page
  36. Morrow, 2013, Early microbial and metabolomic signatures predict later onset of necrotizing enterocolitis in preterm infants, Microbiome, 1, 13, 10.1186/2049-2618-1-13 · DOI · Paper page
  37. Zhou, 2015, Longitudinal analysis of the premature infant intestinal microbiome prior to necrotizing enterocolitis: a case-control study, PLoS One, 10, e0118632, 10.1371/journal.pone.0118632 · DOI · Paper page
  38. Heida, 2016, A necrotizing enterocolitis-associated gut microbiota is present in the meconium: results of a prospective study, Clin Infect Dis, 62, 863, 10.1093/cid/ciw016 · DOI · Paper page
  39. Warner, 2016, Gut bacteria dysbiosis and necrotising enterocolitis in very low birthweight infants: a prospective case-control study, Lancet, 387, 1928, 10.1016/S0140-6736(16)00081-7 · DOI · Paper page
  40. Siu, 1998, Double blind, randomised, placebo controlled study of oral vancomycin in prevention of necrotising enterocolitis in preterm, very low birthweight infants, Arch Dis Child Fetal Neonatal Ed, 79, F105, 10.1136/fn.79.2.F105 · doi:10.1136/fn.79.2.f105
  41. Grylack, 1978, Oral gentamicin therapy in the prevention of neonatal necrotizing enterocolitis. A controlled double-blind trial, Am J Dis Child, 132, 1192, 10.1001/archpedi.1978.02120370040010 · DOI
  42. Boyle, 1978, Alterations in stool flora resulting from oral kanamycin prophylaxis of necrotizing enterocolitis, J Pediatr, 93, 857, 10.1016/S0022-3476(78)81101-9 · doi:10.1016/s0022-3476(78)81101-9
  43. Egan, 1976, A prospective controlled trial of oral kanamycin in the prevention of neonatal necrotizing enterocolitis, J Pediatr, 89, 467, 10.1016/S0022-3476(76)80553-7 · DOI
  44. Rowley, 1978, Gentamicin in prophylaxis of neonatal necrotising enterocolitis, Lancet, 2, 532, 10.1016/S0140-6736(78)92265-1 · doi:10.1016/s0140-6736(78)92265-1
  45. Bury, 2001, Enteral antibiotics for preventing necrotizing enterocolitis in low birthweight or preterm infants, Cochrane Database Syst Rev, CD000405
  46. Haque, 2016, Necrotizing enterocolitis - some things old and some things new: a comprehensive review, J Clin Neonatol, 5
  47. Weintraub, 2012, Antenatal antibiotic exposure in preterm infants with necrotizing enterocolitis, J Perinatol, 32, 705, 10.1038/jp.2011.180 · doi:10.1038/jp.2011.180
  48. Cotten, 2009, Prolonged duration of initial empirical antibiotic treatment is associated with increased rates of necrotizing enterocolitis and death for extremely low birth weight infants, Pediatrics, 123, 58, 10.1542/peds.2007-3423 · DOI · Paper page
  49. Abdel Ghany, 2012, Empirical antibiotic treatment and the risk of necrotizing enterocolitis and death in very low birth weight neonates, Ann Saudi Med, 32, 521, 10.5144/0256-4947.2012.521 · doi:10.5144/0256-4947.2012.521
  50. Kuppala, 2011, Prolonged initial empirical antibiotic treatment is associated with adverse outcomes in premature infants, J Pediatr, 159, 720, 10.1016/j.jpeds.2011.05.033 · DOI · Paper page
  51. Alexander, 2011, Antibiotic exposure in the newborn intensive care unit and the risk of necrotizing enterocolitis, J Pediatr, 159, 392, 10.1016/j.jpeds.2011.02.035 · DOI · Paper page
  52. Lau, 2015, Probiotic administration can prevent necrotizing enterocolitis in preterm infants: a meta-analysis, J Pediatr Surg, 50, 1405, 10.1016/j.jpedsurg.2015.05.008 · DOI
  53. Bartlett, 2002, Clinical practice. Antibiotic-associated diarrhea, N Engl J Med, 346, 334, 10.1056/NEJMcp011603 · DOI · Paper page
  54. Kuehn, 2015, Reported rates of diarrhea following oral penicillin therapy in pediatric clinical trials, J Pediatr Pharmacol Ther, 20, 90
  55. Tedesco, 1974, Clindamycin-associated colitis. A prospective study, Ann Intern Med, 81, 429, 10.7326/0003-4819-81-4-429 · DOI · Paper page
  56. Bartlett, 2009, Clostridium difficile infection: historic review, Anaerobe, 15, 227, 10.1016/j.anaerobe.2009.09.004 · DOI
  57. Vincent, 2015, Antimicrobial Use, Human Gut Microbiota and Clostridium difficile Colonization and Infection, Antibiotics (Basel), 4, 230, 10.3390/antibiotics4030230 · DOI
  58. Larcombe, 2016, Involvement of bacteria other than Clostridium difficile in antibiotic-associated diarrhoea, Trends Microbiol, 24, 463, 10.1016/j.tim.2016.02.001 · DOI
  59. Peeters, 1989, Erythromycin is a motilin receptor agonist, Am J Physiol, 257, G470
  60. Clausen, 1991, Colonic fermentation to short-chain fatty acids is decreased in antibiotic-associated diarrhea, Gastroenterology, 101, 1497, 10.1016/0016-5085(91)90384-W · DOI · Paper page
  61. Young, 2004, Antibiotic-associated diarrhea accompanied by large-scale alterations in the composition of the fecal microbiota, J Clin Microbiol, 42, 1203, 10.1128/JCM.42.3.1203-1206.2004 · DOI · Paper page
  62. Antunes, 2011, Effect of antibiotic treatment on the intestinal metabolome, Antimicrob Agents Chemother, 55, 1494, 10.1128/AAC.01664-10 · DOI · Paper page
  63. Vrieze, 2014, Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity, J Hepatol, 60, 824, 10.1016/j.jhep.2013.11.034 · DOI · Paper page
  64. Mellon, 2000, Effect of oral antibiotics on intestinal production of propionic acid, Arch Dis Child, 82, 169, 10.1136/adc.82.2.169 · DOI · Paper page
  65. Theriot, 2015, Interactions between the gastrointestinal microbiome and Clostridium difficile, Annu Rev Microbiol, 69, 445, 10.1146/annurev-micro-091014-104115 · DOI · Paper page
  66. Wilson, 1983, Efficiency of various bile salt preparations for stimulation of Clostridium difficile spore germination, J Clin Microbiol, 18, 1017, 10.1128/JCM.18.4.1017-1019.1983 · DOI · Paper page
  67. Cohen, 2010, Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA), Infect Control Hosp Epidemiol, 31, 431, 10.1086/651706 · DOI · Paper page
  68. Kaleko, 2016, Development of SYN-004, an oral beta-lactamase treatment to protect the gut microbiome from antibiotic-mediated damage and prevent Clostridium difficile infection, Anaerobe, 41, 58, 10.1016/j.anaerobe.2016.05.015 · DOI
  69. Vincent, 2013, Reductions in intestinal Clostridiales precede the development of nosocomial Clostridium difficile infection, Microbiome, 1, 18, 10.1186/2049-2618-1-18 · DOI · Paper page
  70. Hempel, 2011, Safety of probiotics to reduce risk and prevent or treat disease, Evid Rep Technol Assess (Full Rep), 1
  71. Parkes, 2009, The mechanisms and efficacy of probiotics in the prevention of Clostridium difficile-associated diarrhoea, Lancet Infect Dis, 9, 237, 10.1016/S1473-3099(09)70059-3 · DOI
  72. Goldenberg, 2015, Probiotics for the prevention of pediatric antibiotic-associated diarrhea, Cochrane Database Syst Rev, 10.1002/14651858.CD004827.pub4 · DOI · Paper page
  73. Allen, 2013, Lactobacilli and bifidobacteria in the prevention of antibiotic-associated diarrhoea and Clostridium difficile diarrhoea in older inpatients (PLACIDE): a randomised, double-blind, placebo-controlled, multicentre trial, Lancet, 382, 1249, 10.1016/S0140-6736(13)61218-0 · DOI · Paper page
  74. Ehrhardt, 2016, Saccharomyces boulardii to prevent antibiotic-associated diarrhea: a randomized, double-masked, placebo-controlled trial, Open Forum Infect Dis, 3, ofw011, 10.1093/ofid/ofw011 · DOI · Paper page
  75. Borriello, 2003, Safety of probiotics that contain lactobacilli or bifidobacteria, Clin Infect Dis, 36, 775, 10.1086/368080 · DOI · Paper page
  76. Degnan, 2008, The US Food and Drug Administration and probiotics: regulatory categorization, Clin Infect Dis, 46, S133, 10.1086/523324 · DOI · Paper page

Cited by

See all 110

Metadata

Authors
Silverman, M. A., Konnikova, L., & Gerber, J. S.
Venue
Gastroenterology Clinics of North America
Publisher
Elsevier BV
Published
2017-03
Volume
46
Issue
1
Pages
61-76
ISSN
0889-8553 (ISSN-L)
OpenAlex
W2584698034
Cited by
110
References
24
FWCI
3.40
Type
journal article
Language
en
Open access
green
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.